These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1941629

  • 1. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K, Kamato T, Yamano M, Nishida A, Ito H, Katsuyama Y, Yuki H, Tsutsumi R, Ohta M, Takeda M.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y, Kadowaki M, Tokoro K, Tomoi M, Mori J, Kohsaka M.
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [Abstract] [Full Text] [Related]

  • 8. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K, Yamano M, Kamato T, Akuzawa S.
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [Abstract] [Full Text] [Related]

  • 9. Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
    Kamato T, Miyata K, Ito H, Yuki H, Yamano M, Honda K.
    Jpn J Pharmacol; 1991 Nov; 57(3):387-95. PubMed ID: 1813664
    [Abstract] [Full Text] [Related]

  • 10. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T, Sakamori M, Kawakita T.
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
    Miyata K, Ito H, Yamano M, Hidaka K, Kamato T, Nishida A, Yuki H.
    Eur J Pharmacol; 1993 Dec 07; 250(2):303-10. PubMed ID: 8112388
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
    Ito H, Akuzawa S, Tsutsumi R, Kiso T, Kamato T, Nishida A, Yamano M, Miyata K.
    Neuropharmacology; 1995 Jun 07; 34(6):631-7. PubMed ID: 7566499
    [Abstract] [Full Text] [Related]

  • 13. Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse.
    Eglen RM, Lee CH, Khabbaz M, Fontana DJ, Daniels S, Kilfoil T, Wong EH.
    Neuropharmacology; 1994 Feb 07; 33(2):227-34. PubMed ID: 8035908
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function.
    Kishibayashi N, Ichikawa S, Yokoyama T, Ishii A, Karasawa A.
    Jpn J Pharmacol; 1993 Dec 07; 63(4):495-502. PubMed ID: 8121082
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
    Eglen RM, Lee CH, Smith WL, Johnson LG, Clark R, Whiting RL, Hegde SS.
    Br J Pharmacol; 1995 Feb 07; 114(4):860-6. PubMed ID: 7773547
    [Abstract] [Full Text] [Related]

  • 16. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M, Kamato T, Miyata K.
    Arzneimittelforschung; 1997 Nov 07; 47(11):1242-6. PubMed ID: 9428982
    [Abstract] [Full Text] [Related]

  • 17. Oncogenicity studies of the new serotonin (5-HT)3-receptor antagonist ramosetron in mice and rats.
    Tabata H, Sakai T, Miki H, Suzuki H, Ruckman SA, Read RM, Gopinath C, Healey GF, Barker MH, Chasseaud LF, Gazeley MJ, Ince G, Hedge A.
    Arzneimittelforschung; 1996 Jun 07; 46(6):560-6. PubMed ID: 8767344
    [Abstract] [Full Text] [Related]

  • 18. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY, Choi JI, Yoon MH.
    Eur J Pharmacol; 2004 Oct 19; 502(3):205-11. PubMed ID: 15476746
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML, Bloomquist W, Gidda JS, Lacefield W.
    J Pharmacol Exp Ther; 1989 Jan 19; 248(1):197-201. PubMed ID: 2521513
    [Abstract] [Full Text] [Related]

  • 20. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
    Langlois A, Pascaud X, Junien JL, Dahl SG, Rivière PJ.
    Eur J Pharmacol; 1996 Dec 27; 318(1):141-4. PubMed ID: 9007525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.